1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Ex Vivo
        1.2.3 In Vivo
    1.3 Market by Application
        1.3.1 Global Gene Therapy in Oncology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostics Centers
        1.3.4 Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Therapy in Oncology Market Perspective (2017-2028)
    2.2 Gene Therapy in Oncology Growth Trends by Region
        2.2.1 Gene Therapy in Oncology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gene Therapy in Oncology Historic Market Size by Region (2017-2022)
        2.2.3 Gene Therapy in Oncology Forecasted Market Size by Region (2023-2028)
    2.3 Gene Therapy in Oncology Market Dynamics
        2.3.1 Gene Therapy in Oncology Industry Trends
        2.3.2 Gene Therapy in Oncology Market Drivers
        2.3.3 Gene Therapy in Oncology Market Challenges
        2.3.4 Gene Therapy in Oncology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy in Oncology Players by Revenue
        3.1.1 Global Top Gene Therapy in Oncology Players by Revenue (2017-2022)
        3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy in Oncology Revenue
    3.4 Global Gene Therapy in Oncology Market Concentration Ratio
        3.4.1 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy in Oncology Revenue in 2021
    3.5 Gene Therapy in Oncology Key Players Head office and Area Served
    3.6 Key Players Gene Therapy in Oncology Product Solution and Service
    3.7 Date of Enter into Gene Therapy in Oncology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy in Oncology Breakdown Data by Type
    4.1 Global Gene Therapy in Oncology Historic Market Size by Type (2017-2022)
    4.2 Global Gene Therapy in Oncology Forecasted Market Size by Type (2023-2028)
5 Gene Therapy in Oncology Breakdown Data by Application
    5.1 Global Gene Therapy in Oncology Historic Market Size by Application (2017-2022)
    5.2 Global Gene Therapy in Oncology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gene Therapy in Oncology Market Size (2017-2028)
    6.2 North America Gene Therapy in Oncology Market Size by Type
        6.2.1 North America Gene Therapy in Oncology Market Size by Type (2017-2022)
        6.2.2 North America Gene Therapy in Oncology Market Size by Type (2023-2028)
        6.2.3 North America Gene Therapy in Oncology Market Share by Type (2017-2028)
    6.3 North America Gene Therapy in Oncology Market Size by Application
        6.3.1 North America Gene Therapy in Oncology Market Size by Application (2017-2022)
        6.3.2 North America Gene Therapy in Oncology Market Size by Application (2023-2028)
        6.3.3 North America Gene Therapy in Oncology Market Share by Application (2017-2028)
    6.4 North America Gene Therapy in Oncology Market Size by Country
        6.4.1 North America Gene Therapy in Oncology Market Size by Country (2017-2022)
        6.4.2 North America Gene Therapy in Oncology Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gene Therapy in Oncology Market Size (2017-2028)
    7.2 Europe Gene Therapy in Oncology Market Size by Type
        7.2.1 Europe Gene Therapy in Oncology Market Size by Type (2017-2022)
        7.2.2 Europe Gene Therapy in Oncology Market Size by Type (2023-2028)
        7.2.3 Europe Gene Therapy in Oncology Market Share by Type (2017-2028)
    7.3 Europe Gene Therapy in Oncology Market Size by Application
        7.3.1 Europe Gene Therapy in Oncology Market Size by Application (2017-2022)
        7.3.2 Europe Gene Therapy in Oncology Market Size by Application (2023-2028)
        7.3.3 Europe Gene Therapy in Oncology Market Share by Application (2017-2028)
    7.4 Europe Gene Therapy in Oncology Market Size by Country
        7.4.1 Europe Gene Therapy in Oncology Market Size by Country (2017-2022)
        7.4.2 Europe Gene Therapy in Oncology Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy in Oncology Market Size (2017-2028)
    8.2 Asia-Pacific Gene Therapy in Oncology Market Size by Type
        8.2.1 Asia-Pacific Gene Therapy in Oncology Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gene Therapy in Oncology Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gene Therapy in Oncology Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gene Therapy in Oncology Market Size by Application
        8.3.1 Asia-Pacific Gene Therapy in Oncology Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gene Therapy in Oncology Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gene Therapy in Oncology Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gene Therapy in Oncology Market Size by Region
        8.4.1 Asia-Pacific Gene Therapy in Oncology Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gene Therapy in Oncology Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gene Therapy in Oncology Market Size (2017-2028)
    9.2 Latin America Gene Therapy in Oncology Market Size by Type
        9.2.1 Latin America Gene Therapy in Oncology Market Size by Type (2017-2022)
        9.2.2 Latin America Gene Therapy in Oncology Market Size by Type (2023-2028)
        9.2.3 Latin America Gene Therapy in Oncology Market Share by Type (2017-2028)
    9.3 Latin America Gene Therapy in Oncology Market Size by Application
        9.3.1 Latin America Gene Therapy in Oncology Market Size by Application (2017-2022)
        9.3.2 Latin America Gene Therapy in Oncology Market Size by Application (2023-2028)
        9.3.3 Latin America Gene Therapy in Oncology Market Share by Application (2017-2028)
    9.4 Latin America Gene Therapy in Oncology Market Size by Country
        9.4.1 Latin America Gene Therapy in Oncology Market Size by Country (2017-2022)
        9.4.2 Latin America Gene Therapy in Oncology Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy in Oncology Market Size (2017-2028)
    10.2 Middle East & Africa Gene Therapy in Oncology Market Size by Type
        10.2.1 Middle East & Africa Gene Therapy in Oncology Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gene Therapy in Oncology Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gene Therapy in Oncology Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gene Therapy in Oncology Market Size by Application
        10.3.1 Middle East & Africa Gene Therapy in Oncology Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gene Therapy in Oncology Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gene Therapy in Oncology Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gene Therapy in Oncology Market Size by Country
        10.4.1 Middle East & Africa Gene Therapy in Oncology Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gene Therapy in Oncology Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Company Details
        11.1.2 Bristol-Myers Squibb Business Overview
        11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Introduction
        11.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.1.5 Bristol-Myers Squibb Recent Developments
    11.2 Cold Genesys
        11.2.1 Cold Genesys Company Details
        11.2.2 Cold Genesys Business Overview
        11.2.3 Cold Genesys Gene Therapy in Oncology Introduction
        11.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.2.5 Cold Genesys Recent Developments
    11.3 Advantagene
        11.3.1 Advantagene Company Details
        11.3.2 Advantagene Business Overview
        11.3.3 Advantagene Gene Therapy in Oncology Introduction
        11.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.3.5 Advantagene Recent Developments
    11.4 Amgen
        11.4.1 Amgen Company Details
        11.4.2 Amgen Business Overview
        11.4.3 Amgen Gene Therapy in Oncology Introduction
        11.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.4.5 Amgen Recent Developments
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Details
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Gene Therapy in Oncology Introduction
        11.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.5.5 AstraZeneca Recent Developments
    11.6 Bio-Path Holdings
        11.6.1 Bio-Path Holdings Company Details
        11.6.2 Bio-Path Holdings Business Overview
        11.6.3 Bio-Path Holdings Gene Therapy in Oncology Introduction
        11.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.6.5 Bio-Path Holdings Recent Developments
    11.7 CRISPR Therapeutics
        11.7.1 CRISPR Therapeutics Company Details
        11.7.2 CRISPR Therapeutics Business Overview
        11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Introduction
        11.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.7.5 CRISPR Therapeutics Recent Developments
    11.8 Editas Medicine
        11.8.1 Editas Medicine Company Details
        11.8.2 Editas Medicine Business Overview
        11.8.3 Editas Medicine Gene Therapy in Oncology Introduction
        11.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.8.5 Editas Medicine Recent Developments
    11.9 Geron Corp
        11.9.1 Geron Corp Company Details
        11.9.2 Geron Corp Business Overview
        11.9.3 Geron Corp Gene Therapy in Oncology Introduction
        11.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.9.5 Geron Corp Recent Developments
    11.10 Idera Pharmaceuticals
        11.10.1 Idera Pharmaceuticals Company Details
        11.10.2 Idera Pharmaceuticals Business Overview
        11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Introduction
        11.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.10.5 Idera Pharmaceuticals Recent Developments
    11.11 Intellia Therapeutics
        11.11.1 Intellia Therapeutics Company Details
        11.11.2 Intellia Therapeutics Business Overview
        11.11.3 Intellia Therapeutics Gene Therapy in Oncology Introduction
        11.11.4 Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.11.5 Intellia Therapeutics Recent Developments
    11.12 Johnson & Johnson
        11.12.1 Johnson & Johnson Company Details
        11.12.2 Johnson & Johnson Business Overview
        11.12.3 Johnson & Johnson Gene Therapy in Oncology Introduction
        11.12.4 Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.12.5 Johnson & Johnson Recent Developments
    11.13 Marsala Biotech
        11.13.1 Marsala Biotech Company Details
        11.13.2 Marsala Biotech Business Overview
        11.13.3 Marsala Biotech Gene Therapy in Oncology Introduction
        11.13.4 Marsala Biotech Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.13.5 Marsala Biotech Recent Developments
    11.14 Merck
        11.14.1 Merck Company Details
        11.14.2 Merck Business Overview
        11.14.3 Merck Gene Therapy in Oncology Introduction
        11.14.4 Merck Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.14.5 Merck Recent Developments
    11.15 Mologen AG
        11.15.1 Mologen AG Company Details
        11.15.2 Mologen AG Business Overview
        11.15.3 Mologen AG Gene Therapy in Oncology Introduction
        11.15.4 Mologen AG Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.15.5 Mologen AG Recent Developments
    11.16 Oncolytics Biotech
        11.16.1 Oncolytics Biotech Company Details
        11.16.2 Oncolytics Biotech Business Overview
        11.16.3 Oncolytics Biotech Gene Therapy in Oncology Introduction
        11.16.4 Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.16.5 Oncolytics Biotech Recent Developments
    11.17 Oncosec
        11.17.1 Oncosec Company Details
        11.17.2 Oncosec Business Overview
        11.17.3 Oncosec Gene Therapy in Oncology Introduction
        11.17.4 Oncosec Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.17.5 Oncosec Recent Developments
    11.18 Oncotelic
        11.18.1 Oncotelic Company Details
        11.18.2 Oncotelic Business Overview
        11.18.3 Oncotelic Gene Therapy in Oncology Introduction
        11.18.4 Oncotelic Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.18.5 Oncotelic Recent Developments
    11.19 Shenzhen SiBiono GeneTech
        11.19.1 Shenzhen SiBiono GeneTech Company Details
        11.19.2 Shenzhen SiBiono GeneTech Business Overview
        11.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Introduction
        11.19.4 Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.19.5 Shenzhen SiBiono GeneTech Recent Developments
    11.20 Sillajen Biotherapeutics
        11.20.1 Sillajen Biotherapeutics Company Details
        11.20.2 Sillajen Biotherapeutics Business Overview
        11.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Introduction
        11.20.4 Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.20.5 Sillajen Biotherapeutics Recent Developments
    11.21 Tocagen
        11.21.1 Tocagen Company Details
        11.21.2 Tocagen Business Overview
        11.21.3 Tocagen Gene Therapy in Oncology Introduction
        11.21.4 Tocagen Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.21.5 Tocagen Recent Developments
    11.22 UniQure
        11.22.1 UniQure Company Details
        11.22.2 UniQure Business Overview
        11.22.3 UniQure Gene Therapy in Oncology Introduction
        11.22.4 UniQure Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.22.5 UniQure Recent Developments
    11.23 Ziopharm Oncology
        11.23.1 Ziopharm Oncology Company Details
        11.23.2 Ziopharm Oncology Business Overview
        11.23.3 Ziopharm Oncology Gene Therapy in Oncology Introduction
        11.23.4 Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2017-2022)
        11.23.5 Ziopharm Oncology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Gene Therapy in Oncology Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Ex Vivo
    Table 3. Key Players of In Vivo
    Table 4. Global Gene Therapy in Oncology Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Gene Therapy in Oncology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gene Therapy in Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Gene Therapy in Oncology Market Share by Region (2017-2022)
    Table 8. Global Gene Therapy in Oncology Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Gene Therapy in Oncology Market Share by Region (2023-2028)
    Table 10. Gene Therapy in Oncology Market Trends
    Table 11. Gene Therapy in Oncology Market Drivers
    Table 12. Gene Therapy in Oncology Market Challenges
    Table 13. Gene Therapy in Oncology Market Restraints
    Table 14. Global Gene Therapy in Oncology Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Gene Therapy in Oncology Revenue Share by Players (2017-2022)
    Table 16. Global Top Gene Therapy in Oncology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2021)
    Table 17. Ranking of Global Top Gene Therapy in Oncology Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Gene Therapy in Oncology Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Therapy in Oncology Product Solution and Service
    Table 21. Date of Enter into Gene Therapy in Oncology Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Therapy in Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Gene Therapy in Oncology Revenue Market Share by Type (2017-2022)
    Table 25. Global Gene Therapy in Oncology Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Gene Therapy in Oncology Revenue Market Share by Type (2023-2028)
    Table 27. Global Gene Therapy in Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Gene Therapy in Oncology Revenue Share by Application (2017-2022)
    Table 29. Global Gene Therapy in Oncology Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Gene Therapy in Oncology Revenue Share by Application (2023-2028)
    Table 31. North America Gene Therapy in Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Gene Therapy in Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Gene Therapy in Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Gene Therapy in Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Gene Therapy in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Gene Therapy in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Gene Therapy in Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Gene Therapy in Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Gene Therapy in Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Gene Therapy in Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Gene Therapy in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Gene Therapy in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Gene Therapy in Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Gene Therapy in Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Gene Therapy in Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Gene Therapy in Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Gene Therapy in Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Gene Therapy in Oncology Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Gene Therapy in Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Gene Therapy in Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Gene Therapy in Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Gene Therapy in Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Gene Therapy in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Gene Therapy in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Gene Therapy in Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Gene Therapy in Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Gene Therapy in Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Gene Therapy in Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Gene Therapy in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Gene Therapy in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Bristol-Myers Squibb Company Details
    Table 62. Bristol-Myers Squibb Business Overview
    Table 63. Bristol-Myers Squibb Gene Therapy in Oncology Product
    Table 64. Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 65. Bristol-Myers Squibb Recent Developments
    Table 66. Cold Genesys Company Details
    Table 67. Cold Genesys Business Overview
    Table 68. Cold Genesys Gene Therapy in Oncology Product
    Table 69. Cold Genesys Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 70. Cold Genesys Recent Developments
    Table 71. Advantagene Company Details
    Table 72. Advantagene Business Overview
    Table 73. Advantagene Gene Therapy in Oncology Product
    Table 74. Advantagene Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 75. Advantagene Recent Developments
    Table 76. Amgen Company Details
    Table 77. Amgen Business Overview
    Table 78. Amgen Gene Therapy in Oncology Product
    Table 79. Amgen Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 80. Amgen Recent Developments
    Table 81. AstraZeneca Company Details
    Table 82. AstraZeneca Business Overview
    Table 83. AstraZeneca Gene Therapy in Oncology Product
    Table 84. AstraZeneca Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 85. AstraZeneca Recent Developments
    Table 86. Bio-Path Holdings Company Details
    Table 87. Bio-Path Holdings Business Overview
    Table 88. Bio-Path Holdings Gene Therapy in Oncology Product
    Table 89. Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 90. Bio-Path Holdings Recent Developments
    Table 91. CRISPR Therapeutics Company Details
    Table 92. CRISPR Therapeutics Business Overview
    Table 93. CRISPR Therapeutics Gene Therapy in Oncology Product
    Table 94. CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 95. CRISPR Therapeutics Recent Developments
    Table 96. Editas Medicine Company Details
    Table 97. Editas Medicine Business Overview
    Table 98. Editas Medicine Gene Therapy in Oncology Product
    Table 99. Editas Medicine Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 100. Editas Medicine Recent Developments
    Table 101. Geron Corp Company Details
    Table 102. Geron Corp Business Overview
    Table 103. Geron Corp Gene Therapy in Oncology Product
    Table 104. Geron Corp Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 105. Geron Corp Recent Developments
    Table 106. Idera Pharmaceuticals Company Details
    Table 107. Idera Pharmaceuticals Business Overview
    Table 108. Idera Pharmaceuticals Gene Therapy in Oncology Product
    Table 109. Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 110. Idera Pharmaceuticals Recent Developments
    Table 111. Intellia Therapeutics Company Details
    Table 112. Intellia Therapeutics Business Overview
    Table 113. Intellia Therapeutics Gene Therapy in Oncology Product
    Table 114. Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 115. Intellia Therapeutics Recent Developments
    Table 116. Johnson & Johnson Company Details
    Table 117. Johnson & Johnson Business Overview
    Table 118. Johnson & Johnson Gene Therapy in Oncology Product
    Table 119. Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 120. Johnson & Johnson Recent Developments
    Table 121. Marsala Biotech Company Details
    Table 122. Marsala Biotech Business Overview
    Table 123. Marsala Biotech Gene Therapy in Oncology Product
    Table 124. Marsala Biotech Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 125. Marsala Biotech Recent Developments
    Table 126. Merck Company Details
    Table 127. Merck Business Overview
    Table 128. Merck Gene Therapy in Oncology Product
    Table 129. Merck Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 130. Merck Recent Developments
    Table 131. Mologen AG Company Details
    Table 132. Mologen AG Business Overview
    Table 133. Mologen AG Gene Therapy in Oncology Product
    Table 134. Mologen AG Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 135. Mologen AG Recent Developments
    Table 136. Oncolytics Biotech Company Details
    Table 137. Oncolytics Biotech Business Overview
    Table 138. Oncolytics Biotech Gene Therapy in Oncology Product
    Table 139. Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 140. Oncolytics Biotech Recent Developments
    Table 141. Oncosec Company Details
    Table 142. Oncosec Business Overview
    Table 143. Oncosec Gene Therapy in Oncology Product
    Table 144. Oncosec Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 145. Oncosec Recent Developments
    Table 146. Oncotelic Company Details
    Table 147. Oncotelic Business Overview
    Table 148. Oncotelic Gene Therapy in Oncology Product
    Table 149. Oncotelic Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 150. Oncotelic Recent Developments
    Table 151. Shenzhen SiBiono GeneTech Company Details
    Table 152. Shenzhen SiBiono GeneTech Business Overview
    Table 153. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product
    Table 154. Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 155. Shenzhen SiBiono GeneTech Recent Developments
    Table 156. Sillajen Biotherapeutics Company Details
    Table 157. Sillajen Biotherapeutics Business Overview
    Table 158. Sillajen Biotherapeutics Gene Therapy in Oncology Product
    Table 159. Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 160. Sillajen Biotherapeutics Recent Developments
    Table 161. Tocagen Company Details
    Table 162. Tocagen Business Overview
    Table 163. Tocagen Gene Therapy in Oncology Product
    Table 164. Tocagen Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 165. Tocagen Recent Developments
    Table 166. UniQure Company Details
    Table 167. UniQure Business Overview
    Table 168. UniQure Gene Therapy in Oncology Product
    Table 169. UniQure Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 170. UniQure Recent Developments
    Table 171. Ziopharm Oncology Company Details
    Table 172. Ziopharm Oncology Business Overview
    Table 173. Ziopharm Oncology Gene Therapy in Oncology Product
    Table 174. Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 175. Ziopharm Oncology Recent Developments
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy in Oncology Market Share by Type: 2021 VS 2028
    Figure 2. Ex Vivo Features
    Figure 3. In Vivo Features
    Figure 4. Global Gene Therapy in Oncology Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Diagnostics Centers Case Studies
    Figure 7. Research Institutes Case Studies
    Figure 8. Gene Therapy in Oncology Report Years Considered
    Figure 9. Global Gene Therapy in Oncology Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Gene Therapy in Oncology Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Gene Therapy in Oncology Market Share by Region: 2021 VS 2028
    Figure 12. Global Gene Therapy in Oncology Market Share by Players in 2021
    Figure 13. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Gene Therapy in Oncology Revenue in 2021
    Figure 15. North America Gene Therapy in Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Gene Therapy in Oncology Market Size Market Share by Type (2017-2028)
    Figure 17. North America Gene Therapy in Oncology Market Size Market Share by Application (2017-2028)
    Figure 18. North America Gene Therapy in Oncology Market Size Share by Country (2017-2028)
    Figure 19. United States Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gene Therapy in Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Gene Therapy in Oncology Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Gene Therapy in Oncology Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Gene Therapy in Oncology Market Size Share by Country (2017-2028)
    Figure 25. Germany Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Gene Therapy in Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Gene Therapy in Oncology Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Gene Therapy in Oncology Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Gene Therapy in Oncology Market Size Share by Region (2017-2028)
    Figure 35. China Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Gene Therapy in Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Gene Therapy in Oncology Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Gene Therapy in Oncology Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Gene Therapy in Oncology Market Size Share by Country (2017-2028)
    Figure 45. Mexico Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Gene Therapy in Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Gene Therapy in Oncology Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Gene Therapy in Oncology Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Gene Therapy in Oncology Market Size Share by Country (2017-2028)
    Figure 51. Turkey Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Gene Therapy in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 55. Cold Genesys Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 56. Advantagene Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 57. Amgen Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 58. AstraZeneca Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 59. Bio-Path Holdings Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 60. CRISPR Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 61. Editas Medicine Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 62. Geron Corp Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 63. Idera Pharmaceuticals Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 64. Intellia Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 65. Johnson & Johnson Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 66. Marsala Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 67. Merck Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 68. Mologen AG Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 69. Oncolytics Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 70. Oncosec Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 71. Oncotelic Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 72. Shenzhen SiBiono GeneTech Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 73. Sillajen Biotherapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 74. Tocagen Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 75. UniQure Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 76. Ziopharm Oncology Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed